New nasal spray could offer fast relief for dangerous heart rhythms
NCT ID NCT06716021
Summary
This study is testing whether a nasal spray called etripamil can safely and quickly lower a dangerously fast heart rate during episodes of atrial fibrillation (AFib). About 750 adults with a history of symptomatic AFib will be given either the real spray or a placebo to use at home when they feel an episode starting. The main goal is to see if the spray reduces heart rate more effectively than the placebo within 30 minutes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.